MARKET

TELA

TELA

TELA BIO, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.69
+0.73
+4.57%
Closed 16:00 03/03 EST
OPEN
15.69
PREV CLOSE
15.96
HIGH
17.05
LOW
15.51
VOLUME
34.84K
TURNOVER
--
52 WEEK HIGH
23.55
52 WEEK LOW
5.25
MARKET CAP
240.87M
P/E (TTM)
-7.0919
1D
5D
1M
3M
1Y
5Y
TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021
MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstr...
GlobeNewswire · 2d ago
Israel’s Speedy Vaccination Campaign Now Faces Key Test in Returning to Normal
Officials are combining incentives with threats, offering perks like free meals at Covid-19 vaccination sites while warning that those who don’t get the shot will be shut out of everyday activities.
marketwatch.com · 02/21 17:48
Is TELA Bio (NASDAQ:TELA) Using Too Much Debt?
Simply Wall St. · 02/12 10:16
£22 Million Tel Aviv Penthouse Aims for Gulf Buyer
Buyers from a Arab states are fueling interest in trophy homes amid newly normalized diplomatic relations with Israel, brokerage says
marketwatch.com · 02/09 15:31
TELA Bio to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
MALVERN, Pa., Feb. 04, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstru...
GlobeNewswire · 02/04 12:00
TELA Bio to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
MALVERN, Pa., Feb. 04, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstru...
GlobeNewswire · 02/04 12:00
TELA Bio to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
MALVERN, Pa., Feb. 04, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstru...
GlobeNewswire · 02/04 12:00
TELA Bio guides Q4 and FY20 revenue below consensus
TELA Bio (TELA) reports preliminary Q4 and FY 2020 results. Q4 rand FY20 revenue is expected to be $5.5M - $5.7M (consensus $6.03M) and $18.0M - 18.2M (est. $18.52M), respectively.Cash and
Seekingalpha · 01/14 12:55
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TELA. Analyze the recent business situations of TELA BIO, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TELA stock price target is 20.00 with a high estimate of 22.00 and a low estimate of 18.00.
EPS
Institutional Holdings
Institutions: 66
Institutional Holdings: 9.69M
% Owned: 67.17%
Shares Outstanding: 14.43M
TypeInstitutionsShares
Increased
18
238.05K
New
5
-20.59K
Decreased
15
279.59K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.37%
Healthcare Equipment & Supplies
-2.63%
Key Executives
Chairman/Independent Director
Kurt Azarbarzin
Chairman/Independent Director
Douglas Evans
President/Chief Executive Officer/Co-Founder/Director
Antony Koblish
Co-Founder
Maarten Persenaire
Chief Technology Officer
Skott Greenhalgh
Chief Financial Officer
Nora Brennan
Chief Technology Officer
Ellis Greenhalgh
Other
Peter Murphy
Independent Director
kurt Azarbarzin
Independent Director
Vince Burgess
Independent Director
Lisa Colleran
Independent Director
Federica OBrien
Independent Director
Adele Oliva
Independent Director
Matt Zuga
No Data
About TELA
TELA Bio Inc. is a medical technology company. The Company is focused on designing, developing and marketing tissue reinforcement materials for soft tissue reconstruction. It offers a portfolio of products and solutions for care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Its portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), can be used for ventral hernia repair and abdominal wall reconstruction, inguinal hernia repair and hiatal hernia repair. Its OviTex PRS Reinforced Tissue Matrix (OviTex PRS) addresses needs in plastic and reconstructive surgery. OviTex PRS product is designed for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery.

Webull offers kinds of TELA Bio Inc stock information, including NASDAQ:TELA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TELA stock methods without spending real money on the virtual paper trading platform.